Coloplast A/S develops and markets intimate healthcare products and services worldwide. The company operates through three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit to individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as SpeediCath catheters that offer catherisation for both genders; Peristeen, an anal irrigation system for controlled emptying of the bowels; and Conveen Active urine bags. In addition, it provides wound care products, such as foam dressings under the Biatain brand and hydrocolloid dressing under the Comfeel brand, as well as skin care products, such as bathing and cleansing products, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. It offers disposable products that include prostate catheters and stents used before, during, and after surgery under the Porgès brand; vaginal slings to restore continence; synthetic mesh products to treat weak pelvic floor; and penile implants for men. The company supplies its products to hospitals, institutions, wholesalers, and pharmacies; and directly to users. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Phone45-4911-1111
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$2.31 billion
Profitability
Miscellaneous
Employees10,905
OptionableNot Optionable
COLOPLAST A/S/ADR (OTCMKTS:CLPBY) Frequently Asked Questions
What is COLOPLAST A/S/ADR's stock symbol?
COLOPLAST A/S/ADR trades on the OTCMKTS under the ticker symbol "CLPBY."
How often does COLOPLAST A/S/ADR pay dividends? What is the dividend yield for COLOPLAST A/S/ADR?
COLOPLAST A/S/ADR announced a Semi-Annual dividend on Tuesday, November 6th. Investors of record on Friday, December 7th will be given a dividend of $0.103 per share on Monday, December 24th. The ex-dividend date is Thursday, December 6th. This is a positive change from COLOPLAST A/S/ADR's previous Semi-Annual dividend of $0.04. View COLOPLAST A/S/ADR's Dividend History.
When is COLOPLAST A/S/ADR's next earnings date?
Has COLOPLAST A/S/ADR been receiving favorable news coverage?
News stories about CLPBY stock have been trending positive recently, according to InfoTrie. The research firm ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. COLOPLAST A/S/ADR earned a coverage optimism score of 2.6 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 8.0 out of 10, meaning that recent news coverage is very likely to have an impact on the stock's share price in the next several days.
Who are some of COLOPLAST A/S/ADR's key competitors?
Some companies that are related to COLOPLAST A/S/ADR include Intuitive Surgical (ISRG), Edwards Lifesciences (EW), Zimmer Biomet (ZBH), Smith & Nephew (SNN), Align Technology (ALGN), Steris (STE), WILLIAM DEMANT/ADR (WILYY), MSA Safety (MSA), Wright Medical Group (WMGI), Inogen (INGN), Avanos Medical (AVNS), Establishment Labs (ESTA), Sientra (SIEN), RTI Surgical (RTIX) and Invacare (IVC).
Who are COLOPLAST A/S/ADR's key executives?
COLOPLAST A/S/ADR's management team includes the folowing people:
- Mr. Kristian Villumsen, Pres & CEO (Age 49)
- Mr. Anders Lonning-Skovgaard, Exec. VP & CFO (Age 47)
- Mr. Allan Rasmussen, Exec. VP of Global Operations (Age 52)
- Ellen Bjurgert, VP of Investor Relations
- Ms. Caroline Vagner Rosenstand, VP of Corp. Devel. & Strategy
How do I buy shares of COLOPLAST A/S/ADR?
Shares of CLPBY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is COLOPLAST A/S/ADR's stock price today?
One share of CLPBY stock can currently be purchased for approximately $9.34.
How big of a company is COLOPLAST A/S/ADR?
COLOPLAST A/S/ADR has a market capitalization of $17.91 billion and generates $2.31 billion in revenue each year. The company earns $564.23 million in net income (profit) each year or $0.27 on an earnings per share basis. COLOPLAST A/S/ADR employs 10,905 workers across the globe.
What is COLOPLAST A/S/ADR's official website?
How can I contact COLOPLAST A/S/ADR?
COLOPLAST A/S/ADR's mailing address is HOLTEDAM 1-3, HUMLEBAEK G7, 3050. The company can be reached via phone at 45-4911-1111 or via email at [email protected]
MarketBeat Community Rating for COLOPLAST A/S/ADR (OTCMKTS CLPBY)
MarketBeat's community ratings are surveys of what our community members think about COLOPLAST A/S/ADR and other stocks. Vote "Outperform" if you believe CLPBY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CLPBY will underperform the S&P 500 over the long term. You may vote once every thirty days.
